4D Share Price
NASDAQ: FDMT | Small Cap | Healthcare4D Stock Performance
4D Share Price Today
As of 19 November 2026, 4D Molecular Therapeutics, Inc.'s share price is $10.44. The stock opened at $10.70, compared to its previous close of $10.78. During today's trading session, 4D Molecular Therapeutics, Inc.'s share price traded between $10.31 and $10.97, with an average price of $10.64. Over the past 52 weeks, the stock has recorded a high of $16.91 and a low of $6.96. In terms of performance, 4D Molecular Therapeutics, Inc.'s share price has risen by 5.03% over the last six months and is down 10.69% on a year-on-year basis.
4D Share Price Chart
4D Quarterly Profit & Loss
All figures in USD
4D Annual Profit & Loss
All figures in USD
4D Balance Sheet
All figures in USD Million
4D Cash Flow
All figures in USD Million
About 4D
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
4D Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $11.96 | $10.38 | -12.59% |
Oct 2026 | $14.37 | $11.88 | -17.07% |
Sep 2026 | $14.04 | $14.32 | -3.83% |
Aug 2026 | $10.17 | $14.89 | +46.27% |
Jul 2026 | $13.12 | $10.18 | -23.43% |
Jun 2026 | $9.97 | $13.29 | +33.75% |
May 2026 | $9.01 | $9.94 | +11.94% |
Apr 2026 | $9.63 | $8.88 | -4.41% |
Mar 2026 | $9.34 | $9.29 | -3.93% |
Feb 2026 | $8.85 | $9.67 | +9.14% |
Jan 2026 | $7.59 | $8.86 | +18.45% |
Dec 2025 | $11.43 | $7.48 | -36.01% |